Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Sees Significant Drop in Short Interest

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the recipient of a significant decline in short interest in March. As of March 13th, there was short interest totaling 889 shares, a decline of 65.6% from the February 26th total of 2,586 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average trading volume of 10,559 shares, the short-interest ratio is currently 0.1 days.

Institutional Trading of Fidelity Disruptive Medicine ETF

Several hedge funds have recently bought and sold shares of the stock. Jane Street Group LLC boosted its holdings in shares of Fidelity Disruptive Medicine ETF by 95.4% in the fourth quarter. Jane Street Group LLC now owns 91,414 shares of the company’s stock valued at $2,473,000 after buying an additional 44,630 shares during the period. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Fidelity Disruptive Medicine ETF by 4.6% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 714,991 shares of the company’s stock worth $19,712,000 after acquiring an additional 31,629 shares during the period. BXM Wealth LLC bought a new stake in Fidelity Disruptive Medicine ETF in the 4th quarter valued at $243,000. Vise Technologies Inc. bought a new stake in Fidelity Disruptive Medicine ETF in the 4th quarter valued at $234,000. Finally, Virtu Financial LLC acquired a new position in Fidelity Disruptive Medicine ETF in the 4th quarter worth $228,000.

Fidelity Disruptive Medicine ETF Price Performance

Shares of Fidelity Disruptive Medicine ETF stock traded down $0.64 during trading hours on Friday, hitting $23.63. The company’s stock had a trading volume of 5,108 shares, compared to its average volume of 7,251. The company has a market capitalization of $54.35 million, a PE ratio of 41.33 and a beta of 1.00. The stock has a 50 day moving average of $25.85 and a 200 day moving average of $26.34. Fidelity Disruptive Medicine ETF has a 12 month low of $20.69 and a 12 month high of $29.07.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.